Cognitive Impairment and Dementia in Parkinson's Disease
Identifieur interne :
002143 ( PascalFrancis/Curation );
précédent :
002142;
suivant :
002144
Cognitive Impairment and Dementia in Parkinson's Disease
Auteurs : Karen Marder [
États-Unis]
Source :
-
Movement disorders [ 0885-3185 ] ; 2010.
RBID : Pascal:10-0193490
Descripteurs français
English descriptors
Abstract
Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based on demographic, neurological, neuropsychological, imaging, and genetic investigations have been delineated. The FDA has approved a treatment for PDD, and efforts now are directed toward intervention at earlier stages of cognitive impairment.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 25 |
|---|
| A06 | | | | @2 3 @3 SUP1 |
|---|
| A08 | 01 | 1 | ENG | @1 Cognitive Impairment and Dementia in Parkinson's Disease |
|---|
| A09 | 01 | 1 | ENG | @1 Frontiers of Science and Clinical Advances in Quality of Life in Parkinson's Disease |
|---|
| A11 | 01 | 1 | | @1 MARDER (Karen) |
|---|
| A12 | 01 | 1 | | @1 FAHN (Stanley) @9 ed. |
|---|
| A12 | 02 | 1 | | @1 MARDER (Karen) @9 ed. |
|---|
| A12 | 03 | 1 | | @1 COTE (Lucien) @9 ed. |
|---|
| A12 | 04 | 1 | | @1 REICH (Stephen G.) @9 ed. |
|---|
| A14 | 01 | | | @1 Departments of Neurology, Columbia University @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A14 | 02 | | | @1 Department of Psychiatry, Columbia University @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A14 | 03 | | | @1 Sergievsky Center, Columhia University @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A14 | 04 | | | @1 Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A15 | 01 | | | @1 Department of Neurology, Columbia University College of Physicians and Surgeons @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A18 | 01 | 1 | | @1 Parkinson's Disease Foundation @2 New York, NY @3 USA @9 org-cong. |
|---|
| A20 | | | | @2 S110-S116 |
|---|
| A21 | | | | @1 2010 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000189676130190 |
|---|
| A44 | | | | @0 0000 @1 © 2010 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 104 ref. |
|---|
| A47 | 01 | 1 | | @0 10-0193490 |
|---|
| A60 | | | | @1 P @2 C |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C01 | 01 | | ENG | @0 Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based on demographic, neurological, neuropsychological, imaging, and genetic investigations have been delineated. The FDA has approved a treatment for PDD, and efforts now are directed toward intervention at earlier stages of cognitive impairment. |
|---|
| C02 | 01 | X | | @0 002B17 |
|---|
| C02 | 02 | X | | @0 002B17G |
|---|
| C03 | 01 | X | FRE | @0 Trouble cognitif @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Cognitive disorder @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Trastorno cognitivo @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Démence @5 02 |
|---|
| C03 | 02 | X | ENG | @0 Dementia @5 02 |
|---|
| C03 | 02 | X | SPA | @0 Demencia @5 02 |
|---|
| C03 | 03 | X | FRE | @0 Maladie de Parkinson @2 NM @5 03 |
|---|
| C03 | 03 | X | ENG | @0 Parkinson disease @2 NM @5 03 |
|---|
| C03 | 03 | X | SPA | @0 Parkinson enfermedad @2 NM @5 03 |
|---|
| C03 | 04 | X | FRE | @0 Pathologie du système nerveux @5 04 |
|---|
| C03 | 04 | X | ENG | @0 Nervous system diseases @5 04 |
|---|
| C03 | 04 | X | SPA | @0 Sistema nervioso patología @5 04 |
|---|
| C07 | 01 | X | FRE | @0 Maladie dégénérative @5 37 |
|---|
| C07 | 01 | X | ENG | @0 Degenerative disease @5 37 |
|---|
| C07 | 01 | X | SPA | @0 Enfermedad degenerativa @5 37 |
|---|
| C07 | 02 | X | FRE | @0 Pathologie de l'encéphale @5 38 |
|---|
| C07 | 02 | X | ENG | @0 Cerebral disorder @5 38 |
|---|
| C07 | 02 | X | SPA | @0 Encéfalo patología @5 38 |
|---|
| C07 | 03 | X | FRE | @0 Syndrome extrapyramidal @5 39 |
|---|
| C07 | 03 | X | ENG | @0 Extrapyramidal syndrome @5 39 |
|---|
| C07 | 03 | X | SPA | @0 Extrapiramidal síndrome @5 39 |
|---|
| C07 | 04 | X | FRE | @0 Pathologie du système nerveux central @5 40 |
|---|
| C07 | 04 | X | ENG | @0 Central nervous system disease @5 40 |
|---|
| C07 | 04 | X | SPA | @0 Sistema nervosio central patología @5 40 |
|---|
| N21 | | | | @1 130 |
|---|
| N44 | 01 | | | @1 OTO |
|---|
| N82 | | | | @1 OTO |
|---|
|
|---|
| pR |
| A30 | 01 | 1 | ENG | @1 Symposium of the Parkinson's Disease Foundation @3 South Street Seaport, Manhattan USA @4 2007-10-11 |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000B76
Links to Exploration step
Pascal:10-0193490
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Cognitive Impairment and Dementia in Parkinson's Disease</title>
<author><name sortKey="Marder, Karen" sort="Marder, Karen" uniqKey="Marder K" first="Karen" last="Marder">Karen Marder</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Neurology, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Psychiatry, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Sergievsky Center, Columhia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0193490</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0193490 INIST</idno>
<idno type="RBID">Pascal:10-0193490</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000B76</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002143</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Cognitive Impairment and Dementia in Parkinson's Disease</title>
<author><name sortKey="Marder, Karen" sort="Marder, Karen" uniqKey="Marder K" first="Karen" last="Marder">Karen Marder</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Neurology, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Psychiatry, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Sergievsky Center, Columhia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cognitive disorder</term>
<term>Dementia</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Trouble cognitif</term>
<term>Démence</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
</keywords><front><div type="abstract" xml:lang="en">Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based on demographic, neurological, neuropsychological, imaging, and genetic investigations have been delineated. The FDA has approved a treatment for PDD, and efforts now are directed toward intervention at earlier stages of cognitive impairment.</div>
</front><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA06><s2>3</s2>
<s3>SUP1</s3>
</fA06><fA08 i1="01" i2="1" l="ENG"><s1>Cognitive Impairment and Dementia in Parkinson's Disease</s1>
</fA08><fA09 i1="01" i2="1" l="ENG"><s1>Frontiers of Science and Clinical Advances in Quality of Life in Parkinson's Disease</s1>
</fA09><fA11 i1="01" i2="1"><s1>MARDER (Karen)</s1>
</fA11><fA12 i1="01" i2="1"><s1>FAHN (Stanley)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="02" i2="1"><s1>MARDER (Karen)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="03" i2="1"><s1>COTE (Lucien)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="04" i2="1"><s1>REICH (Stephen G.)</s1>
<s9>ed.</s9>
</fA12><fA14 i1="01"><s1>Departments of Neurology, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14><fA14 i1="02"><s1>Department of Psychiatry, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14><fA14 i1="03"><s1>Sergievsky Center, Columhia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14><fA14 i1="04"><s1>Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14><fA15 i1="01"><s1>Department of Neurology, Columbia University College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15><fA18 i1="01" i2="1"><s1>Parkinson's Disease Foundation</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<s9>org-cong.</s9>
</fA18><fA20><s2>S110-S116</s2>
</fA20><fA21><s1>2010</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000189676130190</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>104 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>10-0193490</s0>
</fA47><fA60><s1>P</s1>
<s2>C</s2>
</fA60><fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC01 i1="01" l="ENG"><s0>Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based on demographic, neurological, neuropsychological, imaging, and genetic investigations have been delineated. The FDA has approved a treatment for PDD, and efforts now are directed toward intervention at earlier stages of cognitive impairment.</s0>
</fC01><fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02><fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Trouble cognitif</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Cognitive disorder</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Trastorno cognitivo</s0>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Démence</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Dementia</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Demencia</s0>
<s5>02</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>04</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07><fN21><s1>130</s1>
</fN21><fN44 i1="01"><s1>OTO</s1>
</fN44><fN82><s1>OTO</s1>
</fN82><pR><fA30 i1="01" i2="1" l="ENG"><s1>Symposium of the Parkinson's Disease Foundation</s1>
<s3>South Street Seaport, Manhattan USA</s3>
<s4>2007-10-11</s4>
</fA30>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002143 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002143 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:10-0193490
|texte= Cognitive Impairment and Dementia in Parkinson's Disease
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
